Akira Ainai
0000-0003-3054-8846
Publication & Citation Trends
Publications
0 total
Serum anti-nucleocapsid antibody correlates of protection from SARS-CoV-2 re-infection regardless of symptoms or immune history
Cited by 2
Semantic Scholar
LC16m8 for Pre-exposure Prophylaxis against Mpox in a High-Risk Population: An Open-Label Randomized Trial.
Cited by 6
Semantic Scholar
Key success factors in clinical trial operation of the smallpox vaccine LC16m8 against mpox in Colombia.
Cited by 2
Semantic Scholar
Prolonged effects of adenoviral vector priming on T-cell cytokine production in heterologous adenoviral vector/mRNA COVID-19 vaccination regimens
Cited by 3
Semantic Scholar
Iguratimod, a Promising Therapeutic Agent for COVID-19 that Attenuates Excessive Inflammation in Mouse Models.
Cited by 1
Semantic Scholar
Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques
Cited by 2
Semantic Scholar
The comparison of pathogenicity among SARS-CoV-2 variants in domestic cats
Cited by 8
Semantic Scholar
Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults.
Cited by 15
Semantic Scholar
Research Topics
Influenza Virus Research Studies
(38)
Respiratory viral infections research
(30)
Immune Response and Inflammation
(23)
SARS-CoV-2 and COVID-19 Research
(21)
Asthma and respiratory diseases
(13)
Affiliations
National Institutes of Health
Tokyo University of Science
National Institute of Infectious Diseases
National Center for Global Health and Medicine
National Influenza Center